Celgene Financial Statements From 2010 to 2024
Celgene financial statements provide useful quarterly and yearly information to potential Celgene investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Celgene financial statements helps investors assess Celgene's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Celgene's valuation are summarized below:Celgene does not presently have any fundamental signals for analysis.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
Check Celgene financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Celgene's main balance sheet or income statement drivers, such as , as well as many indicators such as . Celgene financial statements analysis is a perfect complement when working with Celgene Valuation or Volatility modules.
Celgene |
Celgene Company Operating Margin Analysis
Celgene's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Celgene Operating Margin | 51.47 % |
Most of Celgene's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Celgene is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
CompetitionBased on the recorded statements, Celgene has an Operating Margin of 51%. This is 246.72% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The operating margin for all United States stocks is notably lower than that of the firm.
Celgene Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Celgene's current stock value. Our valuation model uses many indicators to compare Celgene value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Celgene competition to find correlations between indicators driving Celgene's intrinsic value. More Info.Celgene is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 1,400 of Return On Asset per Return On Equity. Comparative valuation analysis is a catch-all technique that is used if you cannot value Celgene by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Consideration for investing in Celgene Stock
If you are still planning to invest in Celgene check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Celgene's history and understand the potential risks before investing.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |